Article thumbnail

Activating Transcription Factor 3 and the Nervous System

By David Hunt, Gennadij Raivich and Patrick Norval Anderson

Abstract

Activating transcription factor 3 (ATF3) belongs to the ATF/cyclic AMP responsive element binding family of transcription factors and is often described as an adaptive response gene whose activity is usually regulated by stressful stimuli. Although expressed in a number of splice variants and generally recognized as a transcriptional repressor, ATF3 has the ability to interact with a number of other transcription factors including c-Jun to form complexes which not only repress, but can also activate various genes. ATF3 expression is modulated mainly at the transcriptional level and has markedly different effects in different types of cell. The levels of ATF3 mRNA and protein are normally very low in neurons and glia but their expression is rapidly upregulated in response to injury. ATF3 expression in neurons is closely linked to their survival and the regeneration of their axons following axotomy, and that in peripheral nerves correlates with the generation of a Schwann cell phenotype that is conducive to axonal regeneration. ATF3 is also induced by Toll-like receptor (TLR) ligands but acts as a negative regulator of TLR signaling, suppressing the innate immune response which is involved in immuno-surveillance and can enhance or reduce the survival of injured neurons and promote the regeneration of their axons

Topics: Neuroscience
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3278981
Provided by: PubMed Central

Suggested articles

Citations

  1. (2010).Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
  2. (2011). 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death.
  3. (1992). A comprehensivemacrophage-T-lymphocytetheoryof schizophrenia.Med.Hypotheses 39,
  4. (2009). A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3.
  5. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.
  6. (1984). A qualitative comparison of the reactions of retinal ganglion cell axonstoopticnervecrushinneonatal and adult mice.
  7. (2011). A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage.
  8. (2006). A splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator.
  9. (2005). A transcriptional role for C/EBPbetaintheneuronalresponse to axonal injury.
  10. (2010). Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates.
  11. (2010). Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.
  12. (2010). Activating transcription factor 3 (ATF3) expression in the neural retina and optic nerve of zebrafish during optic nerve regeneration.
  13. (2000). Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury.
  14. (2007). Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages.
  15. (2012). Activating transcription factor 3 and the nervous system.
  16. (2010). Activating transcription factor 3 confers protection against ventilator-induced lung injury.
  17. (2009). Activating transcription factor 3 constitutes a negative feedback mechanismthatattenuatessaturated fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue.
  18. (2007). Activating transcription factor 3 immunoreactivity identifies small populations of axotomized neurons in rat cervical sympathetic ganglia after transection of the preganglionic cervical sympathetic trunk. Brain Res.
  19. (2007). Activating transcription factor 3 induction in sympathetic neurons after axotomy: response to decreased neurotrophin availability.
  20. (2011). Activating transcription factor 3, a useful marker for regenerative response after nerve root injury.
  21. (2005). Activating transcription factor3,astresssensor,activatesp53by blockingitsubiquitination.EMBOJ.
  22. (2008). Activating transcription factor3isanegativeregulatorofallergic pulmonary inflammation.
  23. (2011). Activatingtranscriptionfactor3regulates survivability and migration of vascular smooth muscle cells.
  24. (2010). Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection.
  25. (2003). Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple activating transcription factor-3 mRNA species that, when overexpressed in HepG2 cells, modulate transcription by the human asparagine synthetase promoter.
  26. (2002). An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli.
  27. (2007). An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res.
  28. (1996). Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10.Mol.Cell.Biol.16,
  29. and Noguchi,K.(2001).Differentialregulation of P2X(3) mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia.
  30. andWang,X.H.(2008).Inactivation of ID-1 gene induces sensitivity of prostate cancer cells to chemotherapeutic drugs.
  31. (2008). are necessary forsynapticplasticityandfunctional recovery after stroke.
  32. (2006). Astrocyte-derived transgene GDNF promotes complete and long-term survival of adult facial motoneurons following avulsion and differentially regulates the expression of transcription factors of AP-1 and ATF/CREB families.
  33. (1994). ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternativelysplicedisoforms.J.Biol.Chem.
  34. ATF3 and PU.1 as important transcription factors.
  35. (2007). ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration.
  36. (2002). ATF3 induction following DNA damage is regulated by distinct signaling pathways andover-expressionofATF3protein suppresses cells growth.
  37. ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line. Brain Res.
  38. (2004). ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matter.
  39. (2010). ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
  40. (2003). ATF3enhancesc-Jun-mediatedneurite sprouting. Brain Res.
  41. (2008). Axonal guidance molecules and the failure of axonal regeneration in the adult mammalian spinal cord.
  42. (2008). Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylationandactivationtranscription factor3expression.Exp.Neurol.209,
  43. (1994). Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat’s infraorbital nerve.
  44. (2011). Biochemical specificity of von economo neurons in hominoids.
  45. (2003). Biphasic expression of activating transcription factor-3 in neurons after cerebral infarction. Brain Res.
  46. C.J.(2006).Thetranscriptionfactor ATF-3 promotes neurite outgrowth.
  47. (1998). Cellular and molecular correlates of the regeneration of adult mammalian CNS axons into peripheral nerve grafts.
  48. (2009). CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade.
  49. (2010). Characterization of the acute and persistent pain state present in K/BxN serum transferarthritis.Pain 151,394–403.
  50. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury.
  51. (2003). Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression followingchronicconstrictioninjuryofthe sciaticnerveinrats.Pain 101,65–77.
  52. (2003). Corticospinal neurons up-regulate a range of growth-associated genes following intracortical, but not spinal, axotomy.
  53. (1996). Cross-linking of T-cell receptorsondouble-positivethymocytes induces a cytokine-mediated stromal activation process linked to cell death.
  54. (1991). Crossfamily dimerization of transcription factorsFos/JunandATF/CREBalters DNA binding specificity.
  55. (2010). Damage-induced neuronal endopeptidase is critical for presynaptic formation of neuromuscular junctions.
  56. (2008). Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons.
  57. (2004). Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
  58. (1928). Degeneration and Regeneration in the Nervous System. London:
  59. (2001). Degeneration andsproutingof identifieddescendingsupraspinalaxonsaftercontusive spinal cord injury in the rat.
  60. (2008). Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction.
  61. (2010). Demyelination increases axonalstationarymitochondrialsize and the speed of axonal mitochondrial transport.
  62. (1999). Demyelination: the role of reactiveoxygenandnitrogenspecies.
  63. (2003). Different effects of astrocytes and Schwann cells on regenerating retinal axons.
  64. (2010). Different susceptibility to the Parkinson’s toxin MPTP in mice lacking the redox master regulator
  65. (2010). Differential ATF3 expression in dorsal root ganglion neurons reveals the profile of primary afferents engaged by diverse noxious chemical stimuli.
  66. (2008). Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats.
  67. (1993). Differential regenerative growth of CNS axons into tibial and peronealnervegraftsinthethalamus ofadultrats.Exp.Neurol.120,60–69.
  68. (2009). Differential usage of alternate promoters of the human stress response gene ATF3 in stress response and cancer cells.
  69. (2009). Does elevated intraocular pressure reduce retinal TRKB-mediated survivalsignalinginexperimentalglaucoma?
  70. (2008). Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
  71. Dynamicpatternof reg-2expression in rat sensory neurons after peripheral nerve injury.
  72. (2011). Early gene expression changes in the retinal ganglion cell layerofaratglaucomamodel.Invest.
  73. (2006). Effects of lipopolysaccharide-induced inflammation on expression of growthassociated genes by corticospinal neurons.
  74. (2009). ER stress and unfolded protein response in amyotrophic lateral sclerosis.
  75. (2009). Experimentalarthritiscausestumornecrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates withpain-relatedbehavior.Pain145,
  76. (2002). Expression of activating transcription factor 3 and growth-associated protein 43 in the ratgeniculateganglionneuronsafter chorda tympani injury.
  77. (2009). Expression of ATF3 and axonal outgrowth are impaired after delayed nerve repair.
  78. (2003). Expression of auxiliary beta subunits of sodium channels in primary afferent neurons and the effect of nerve injury.
  79. (2004). Expression of damageinduced neuronal endopeptidase (DINE) mRNA in peri-infarct cortical and thalamic neurons following middle cerebral artery occlusion.
  80. (2010). Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes.
  81. (2003). Expression of the activatingtranscriptionfactor3preventscJunN-terminalkinase-inducedneuronaldeathbypromotingheatshock protein 27 expression and Akt activation.
  82. (2002). Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvementincelldeathof vascular endothelial cells.
  83. (1993). Fate of severed cortical projection axons.
  84. (2012). Frontiers in Molecular Neuroscience www.frontiersin.org
  85. (2009). Function of C/EBPdelta in a regulatory circuitthatdiscriminatesbetweentransient and persistent TLR4-induced signals.
  86. (1997). gadd153/Chop10, a potentialtargetgeneof thetranscriptional repressor ATF3.
  87. H.,andWoolf,C.J.(1999).Arolefor HSP27insensoryneuronsurvival.J.
  88. (2006). Heat s h o c kp r o t e i n2 7i si n v o l v e di n neurite extension and branching of dorsal root ganglion neurons in vitro.
  89. (2012). Hyperoxiainduced activation of the integrated stress response in the newborn rat lung.
  90. (1991). Identification of LRF-1, a leucine-zipperproteinthatisrapidly and highly induced in regenerating liver.
  91. (2007). Immune cell involvement in dorsal root ganglia and spinal cord after chronic constrictionortransectionof therat sciatic nerve.
  92. (2011). In vivo imaging reveals a phase-specific role of STAT3duringcentralandperipheral nervous system axon regeneration.Proc.Natl.Acad.Sci.U.S.A.108,
  93. (2007). Induction of activating transcription factor 3 after different sciatic nerve injuries in adult rats.
  94. (2007). Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway.
  95. (2008). Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior.
  96. (2005). Induction of plasminogenactivatorinhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury.
  97. (2011). Induction of the unfolded protein response by α synuclein in experimental models of
  98. (1991). Inflammation near the nerve cell body enhances axonal regeneration.
  99. (2010). Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.
  100. (2000). Injury-specificexpressionof activating transcription factor-3 in retinal ganglion cells and its colocalized expression with phosphorylated cJun.
  101. (1992). Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liverregeneration.Mol.Cell.Biol.12,
  102. (2007). Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.
  103. (1999). Intrinsic determinants of differential axonal regeneration by adult mammalian CNS neurons,”in DegenerationandRegenerationinthe Nervous System, eds
  104. (2010). Involvement of nerve injury and activation of peripheral glial cells in tetanic sciatic stimulation-induced persistent pain in rats.
  105. (2001). Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agentinduced apoptosis.
  106. (2011). Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene.d o i : 10.1038/onc.2011.397. [Epub ahead of print].
  107. (2000). Lens injury stimulates axon regeneration in the mature rat optic nerve.
  108. (2003). Macrophage-derived factors stimulate optic nerve regeneration.
  109. (2010). MDM2 mediates ubiquitination and degradation of activating transcription factor 3.
  110. (2009). Methamphetamine induces dopamine D1 receptordependent endoplasmic reticulum stress-relatedmoleculareventsinthe rat striatum.
  111. (2010). Microglial responses around intrinsic CNS neurons are correlated with axonal regeneration.
  112. (2007). Negative regulation of TLR-signaling pathways by activating transcription factor-3.
  113. (2008). Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons.
  114. (2004). Novel changesingeneexpressionfollowing axotomy of a sympathetic ganglion: a microarray analysis.
  115. (1999). NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord.
  116. (2011). olfactory neurosphere-derived cells from patients with sporadic Parkinson’s disease.
  117. (2004). Over expression of ATF-3 protects rat hippocampal neurons from in vivo injection of kainicacid.BrainRes.Mol.BrainRes.
  118. (2006). Oxidative stress-triggered unfolded proteinresponseisupstreamofintrinsic cell death evoked by Parkinsonian mimetics.
  119. (2010). p53-Mediated neuronal cell death in ischemic brain injury.
  120. (2000). Patterns of expression and distribution of mRNAs for L1, CHL1, c-Jun and GAP-43 in identified regenerating neurons of the cerebellum and brainstem of the adult rat.
  121. (2011). Pelvic nerve injury causes a rapid decrease in expression of choline acetyltransferase and upregulation of c-Jun and ATF-3 in a distinct population of sacral preganglionicneurons.Front.Neurosci.5:6.
  122. (2009). Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury.
  123. (2006). Profiles of growth hormone (GH)-regulated genes reveal timedependent responses and identify a mechanismforregulationofactivating transcription factor 3 by GH.
  124. (2003). Rapid and preferential induction of ATF3 transcription in response to low doses of UVA light.
  125. (2008). Regeneration of axons in the visual system.
  126. Regenerative and other responses to injury in the retinal stump of the optic nerve in adult albino rats: transection of the intraorbital optic nerve.
  127. (1999). Regulation of fibronectin alternative splicing during peripheral nerve repair.
  128. (2003). Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMPresponse element/ATF site of the proglucagon gene promoter.
  129. (1997). Repair of adult rat corticospinaltractbytransplantsofolfactory ensheathing cells.
  130. Retrograde axonal transport of JNK signaling molecules influence injury induced nuclear changes in p-c-Jun Frontiers
  131. (2004). Role for activating transcription factor 3 in stress-induced beta-cell apoptosis.
  132. (2011). Salermide upregulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells.
  133. (1999). Scanning gene expression during neuronal cell death evoked by nerve growth factor depletion.
  134. (2006). Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat.
  135. (2002). Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth.
  136. (2010). SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury.
  137. (2009). Sox11 transcription factor modulatesperipheralnerveregeneration in adult mice. Brain Res.
  138. (2006). Spinal cord compression and dorsal root injury cause up-regulation of activating transcription
  139. (1999). Spontaneous regeneration after optic nerve injury in adult rat.
  140. (1999). Sprouting and regeneration after pyramidotomy and blockade of the myelin-associated neurite growth inhibitors NI 35/250 in adult rats.
  141. (2011). Steroids and extracellular signal-regulated kinase 1/2 activity suppress activating transcription factor 3 expression in patients with severe asthma.
  142. Stress response geneATF3 is a target of c-myc in serum-induced cell proliferation.
  143. (2001). Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms.
  144. (2007). Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation.
  145. (2006). Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.
  146. (2009). Systems analysis of ATF3 in stress response and cancer reveals opposingeffectsonpro-apoptoticgenesin p53 pathway.
  147. (2006). Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.
  148. (1997). Temporal variability of Jun family transcription factor levels in peripherally or centrally transected adult rat dorsal root ganglia. Brain Res.
  149. (2004). The AP-1 transcription factor c-Jun is required for efficient axonal regeneration.
  150. (2006). The ATF transcription factors in cellular adaptive responses,”
  151. (1971). The axon reaction: a review of the principal features of perikaryal responses to axon injury.
  152. (2010). The conditioning lesion effect on sympathetic neurite outgrowth is dependent on gp130 cytokines.
  153. (2009). The dependence on gp130 cytokines of axotomy induced neuropeptide expressioninadultsympatheticneurons.
  154. (2010). The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic betacell apoptosis and its dysfunction in streptozotocin-treated mice.
  155. (2001). The molecular biology and nomenclature of the activating transcription factor/cAMP responsive elementbindingfamilyoftranscription factors: activating transcription factor proteins and homeostasis.
  156. (2007). The regulation of ATF3 gene expression by mitogen-activated protein kinases.
  157. (2008). The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis.
  158. (2001). The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas.
  159. (2009). The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3.
  160. (1997). Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney.J.Biol.Chem.272,19943–19950. Yin,X.,Dewille,J.W.,andHai,T.(2008). A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.
  161. (2005). Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferongamma-induced apoptosis in primary pancreatic beta-cells.
  162. (1989). Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNAbinding heterodimers.
  163. (2001). Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
  164. (2010). Transcriptional profiling of the injured sciatic nerve of mice carrying the Wld(S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration.
  165. (2002). Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription.
  166. (2011). TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders.
  167. (2005). Upregulation of activating transcription factor 3 (ATF3) by intrinsic CNS neurons regenerating axons into peripheral nerve grafts.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.